KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Equity Income (2021 - 2025)

Historic Equity Income for Thermo Fisher Scientific (TMO) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Thermo Fisher Scientific's Equity Income rose 11428.57% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 13026.32%. This contributed to the annual value of -$42.0 million for FY2024, which is 2881.36% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Equity Income of $2.0 million as of Q3 2025, which was up 11428.57% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Equity Income peaked at $33.0 million during Q4 2024, and registered a low of -$84.0 million during Q2 2024.
  • Its 5-year average for Equity Income is -$16.9 million, with a median of -$14.0 million in 2024.
  • Its Equity Income has fluctuated over the past 5 years, first plummeted by 500000.0% in 2022, then soared by 340000.0% in 2024.
  • Thermo Fisher Scientific's Equity Income (Quarter) stood at -$3.0 million in 2021, then tumbled by 900.0% to -$30.0 million in 2022, then skyrocketed by 96.67% to -$1.0 million in 2023, then surged by 3400.0% to $33.0 million in 2024, then plummeted by 93.94% to $2.0 million in 2025.
  • Its Equity Income was $2.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and -$14.0 million in Q1 2025.